SUBSCRIBE
SUBSCRIBE
News   Drug Development

Merck & Co., Inc. (Jobs) and Schering-Plough Corporation (Jobs) Cholesterol Trial Faces Probe

December 12, 2007 | 
1 min read
LOS ANGELES, Dec 11 (Reuters) - Schering-Plough SGP.N and Merck & Co MRK.N are being investigated by U.S. lawmakers on allegations that the drugmakers are withholding data from a study that may change how doctors treat high cholesterol.
Clinical research Phase 1 Phase 2 Legal Regulatory
Merck & Co.
MORE ON THIS TOPIC
Stagflation, economic slow down or recession while inflation high up, GDP growth decrease causing by unemployment concept, fearful businessman riding fall down economic graph with inflation high up.
Cardiovascular disease
AstraZeneca, Ionis slip as ATTR-CM drug fails Phase 3
July 9, 2026
 · 
3 min read
 · 
Tristan Manalac
Winter season driving tips and traffic regulation rules. Heavy snow covered "snow and ice" road sign. Close-up view. Flat vector illustration template.
Complete response letters
FDA freezes CRL trove as ‘radical transparency’ push hits speedbump
July 9, 2026
 · 
2 min read
 · 
Tristan Manalac
Podcast
Vertex carries M&A uptick into H2, IPOs and VC raises also grow, FDA on pace despite turmoil
July 8, 2026
 · 
1 min read
 · 
Jef Akst
Digital scanning effect of human kidneys glowing in blue, highlighting intricate details with a futuristic design. The image emphasizes respiratory system anatomy and health.
Approvals
Vera moves into growing kidney disease space with FDA’s accelerated IgAN nod
July 7, 2026
 · 
2 min read
 · 
Annalee Armstrong